Chinese Medical Journal (May 2022)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review

Ruyi Cai,
Zixi Yi,
Ting Li,
Rong Mu,
Lishao Guo

Affiliations

Ruyi Cai: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Zixi Yi: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Ting Li: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Rong Mu: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.
Lishao Guo: Department of Rheumatology and Immunology, Peking University Third Hospital, Beijing 100191, China.

DOI: https://doi.org/10.1097/CM9.0000000000001903
Journal volume & issue: Vol. 135, no. 9
pp. 1133 – 1134

Abstract

No abstracts available.

Published in Chinese Medical Journal

ISSN: 0366-6999 (Print); 2542-5641 (Online)
Publisher: Wolters Kluwer
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://journals.lww.com/cmj/pages/default.aspx

About the journal